Pharmafile Logo

Patients and data tracking

Breaking Down the Wall: Blockchain in Healthcare and Pharma

Ray Dogum, Senior Consultant and Blockchain Strategist at ConsenSys Health and Podcaster at Health Unchained, explores blockchain in Pharma and healthcare, including innovative use cases, current barriers, and how to...

Impetus Digital

Building Better Patient Advocates Through Authentic Partnerships

Sabrina Hanna, Founder & CIO of the Cancer Collaborative, discusses precision medicine, innovation in oncology, how to build better patient advocates, and the current gaps when it comes to patient-centricity...

Impetus Digital

- PMLiVE

Virgo Health makes two hires to leadership team

Amanda Moulson joins as executive director, while Gregor Fyfe has been appointed as senior scientific director at the agency

- PMLiVE

Hanover Health appoints Aleksandra Lugović as an associate director

Lugović joins Hanover's international policy and market access team

- PMLiVE

GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy

'New' GSK will build on growth potential of its vaccines and speciality medicines portfolios

- PMLiVE

Teva reaches $925,000 settlement to resolve drug price-fixing claims

Last year, the US Department of Justice charged Teva for conspiring with competitors in a generic drug price-fixing probe

- PMLiVE

AZ, HUTCHMED win first approval for MET inhibitor Orpathys in China

Continued approval in MET-positive NSCLC is contingent on the completion of a positive confirmatory trial

- PMLiVE

Starting a career in medical communications – experiences from the Nucleus Academy

Two graduates of the Nucleus Academy training programme share their experiences of the Academy and their medical communications careers to date.

Nucleus Global

- PMLiVE

EFPIA confirms first and second vice-presidents

Novo Nordisk CEO Lars Fruergaard Jørgensen appointed first vice-president and Servier president Olivier Laureau confirmed as second vice-president

- PMLiVE

Great expectations

Maybe we can learn something from the Golem and Pygmalion effects

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links